From November 17th to 20th, MEDICA 2025, the world’s premier medical extravaganza, grandly took place in Düsseldorf, Germany.

Amid this feast of ideas gathering global cutting-edge technology and medical wisdom, we outlined the future blueprint of the healthcare industry through frontier technologies, innovative products, and in-depth dialogues.

Chinese Solutions on the International Stage

Bringing its latest technological achievements and industry insights, Kossel explored cutting-edge trends with global partners. A number of innovative achievements and solutions across three major product lines—Peripheral Vascular, Coronary, and Electrophysiology—made a stunning debut, demonstrating the innovative vitality of Chinese medical enterprises on the global stage.

During the exhibition, we conducted in-depth negotiations with agents and physician representatives from multiple countries in Europe, the Americas, Asia, and other regions. While discussing product features, we accurately aligned with registration requirements and clinical needs, laying a solid foundation for the deepening of future cooperation.

Europe is Kossel’s key strategic market. The company successfully obtained MDR CE certification in May this year, removing critical barriers for product entry into the European market. In the future, we will continue to launch more high-quality products, continuously enhance brand influence and market share, and support the company’s long-term development in Europe.

Every medical technology event marks the starting point of a new journey. We will embark on the next phase with the trust of global partners, persist in innovative R&D, advance the global market layout in parallel, focus deeply on the application needs in the pan-vascular intervention field, and provide more innovative and practical products and solutions for physicians and patients worldwide.